S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy such as gemcitabine and capecitabine use different ways
to stop tumor cells from dividing so they stop growing or die. Combining more than one
chemotherapy drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining gemcitabine with capecitabine
in treating patients who have advanced renal cell cancer (kidney cancer).